Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Novavax Announces Selection Of A Respiratory Syncytial Virus Vaccine Candidate For Advanced Preclinical Studies
Novavax, Inc. (Nasdaq: NVAX) announced final selection of a Respiratory Syncytial Virus (RSV) vaccine candidate that will be advanced into additional preclinical studies to support an Investigational New Drug (IND) application. As previously announced, Novavax has been evaluating a number of RSV vaccine candidates, all of which have successfully induced antibody responses in mice. Novavax scientists have now engineered a new vaccine candidate which has been shown to protect mice against RSV disease and can be produced at sufficient yields to allow commercial manufacture. This new candidate is directed against a protein on the surface of the virus, the "F" or "fusion" protein, which is the protein that the virus uses to infect and fuse with cells in the respiratory tract and cause disease.
generic viagra online
Obama Highlights Health Care Reform Progress In Weekly Address
In his weekly radio and Internet address, President Obama discussed efforts by congressional leaders and health care industry groups on health care reform legislation, The Hill reports. He said that "while there remains a great deal of difficult work ahead, I am heartened by what we have seen these past few days: a willingness of those with different points of view and disparate interests to come together around common goals -- to embrace a shared sense of responsibility and make historic progress" (Youngman, The Hill, 5/16). He said, "I have always believed that it is better to talk than not to talk, that it is far more productive to reach over a divide than to shake your fist across it," which has "been an alien notion in Washington for far too long, but we are seeing that the ways of Washington are beginning to change."In the Republican radio and Internet address. Rep. Charles Boustany (R-La.), a cardiovascular surgeon, said that a "government takeover of health care will put bureaucrats in charge of health care decisions that should be made by families and doctors." He added, "It will limit treatment options and lead to rationed care," and "to pay for government health care, your taxes will be raised." Boustany, a member of the House Republican Health Care Solutions Group, said, "That is something we cannot support, and frankly, it would clearly violate some of the principles the president himself has endorsed" (Superville, AP/Washington Post, 5/16). In related news, Office of Management and Budget Director Peter Orszag on Sunday said on CNN"s "State of the Union" that the administration might support taxing health care benefits to health pay for health care reform (Barr, Politico, 5/17). Timeline
News of the day
Health Unit Reports Three Cases Of E. Coli O157:H7 In London
Over the last five days, the Middlesex-London Health Unit has received reports of three children with E. coli O157:H7. To receive three laboratory confirmed cases of E. coli O157:H7 in such a short timeframe is unusual. In two of these cases, the common food consumed was kofta (spiced ground beef) purchased on June 14 and 15 from the Westmount Halal Food Store located at 490 Wonderland Road South. The of the third child"s infection is currently unknown. This child"s family also eats halal food but did not purchase any food from the Westmount Halal Food Store.
Medical Devices

HearAtLast To Launch Exclusive Groundbreaking Neuro-CompensatorTM Technology Hearing Aids From VitaSound

HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced that in keeping with its tradition of bringing innovative new products to consumers, the Company announces the unveiling of breakthrough hearing products based on the Neuro-Compensator™ algorithm technology from VitaSound Audio. The NEURO-COMPENSATOR™ hearing instruments are powered by the newest groundbreaking neuro-biological technology designed to optimize the auditory nerve output. Based on many years of research at McMaster University into the electrical signals that are transmitted to the brain by the auditory nerves in healthy and impaired ears, this patented technology is designed to significantly improve the perceived audio quality in hearing devices. Using standard audiometric test data, the algorithm engine derives a customized map of an individual"s auditory system and configures the hearing device to optimize auditory nerve output for that individual. Clarity of sound, perception of true pitch, and more normal perception of own voice are just some of the benefits noted by trial subjects. "Neuro-Compensation represents a unique Canadian story from research at McMaster University, development at VitaSound, to market launch at our retail locations in Wal-Mart Canada stores," said Matthew Sacco, CEO of HearAtLast. "This underscores our commitment to being first to bring innovative new technologies to consumers." Available first in Canada exclusively at selected HearAtLast locations in mid-April, products will be generally available throughout the chain by the end of May. About VitaSound VitaSound"s mission is to develop and bring to market hearing solutions that are unique and innovative, but also accessible and affordable, to enable all individuals to benefit from better communications and quality of life. We focus on total hearing healthcare which involves protection, preservation, care and improvement, all in the context of today"s active lifestyles. For more information on VitaSound Audio, Inc., please visit: http://www.vitasound.com HearAtLast


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009